SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 70 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 20.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 50 | -50.0% | 0.00% | – |
| Q1 2022 | $2,000 | +100.0% | 100 | +100.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | – | 50 | – | 0.00% | – |
| Q2 2021 | $0 | – | 0 | -100.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 22 | -80.0% | 0.00% | – |
| Q4 2020 | $1,000 | -85.7% | 110 | -78.0% | 0.00% | – |
| Q3 2017 | $7,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
| IFP Advisors, Inc | 50 | $1,000 | 0.00% |
| Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |